Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
LPI (LP Information)' newest research report, the “Cell Therapy Regenerative Medicine Industry Forecast” looks at past sales and reviews total world Cell Therapy Regenerative Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Therapy Regenerative Medicine sales for 2023 through 2029. With Cell Therapy Regenerative Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy Regenerative Medicine industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Therapy Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cell Therapy Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy Regenerative Medicine.
The global Cell Therapy Regenerative Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Therapy Regenerative Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Therapy Regenerative Medicine players cover DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy Regenerative Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
NK Cell Therapy
CAR-T Cell Therapy
Others
Segmentation by application
Dermatology
Cardiovascular
Central Nervous System
Plastic Surgery
Other Medical Applications
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cell Therapy Regenerative Medicine market?
What factors are driving Cell Therapy Regenerative Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cell Therapy Regenerative Medicine market opportunities vary by end market size?
How does Cell Therapy Regenerative Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Cell Therapy Regenerative Medicine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Cell Therapy Regenerative Medicine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Cell Therapy Regenerative Medicine by Country/Region, 2018, 2022 & 2029 2.2 Cell Therapy Regenerative Medicine Segment by Type 2.2.1 NK Cell Therapy 2.2.2 CAR-T Cell Therapy 2.2.3 Others 2.3 Cell Therapy Regenerative Medicine Sales by Type 2.3.1 Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023) 2.3.2 Global Cell Therapy Regenerative Medicine Revenue and Market Share by Type (2018-2023) 2.3.3 Global Cell Therapy Regenerative Medicine Sale Price by Type (2018-2023) 2.4 Cell Therapy Regenerative Medicine Segment by Application 2.4.1 Dermatology 2.4.2 Cardiovascular 2.4.3 Central Nervous System 2.4.4 Plastic Surgery 2.4.5 Other Medical Applications 2.5 Cell Therapy Regenerative Medicine Sales by Application 2.5.1 Global Cell Therapy Regenerative Medicine Sale Market Share by Application (2018-2023) 2.5.2 Global Cell Therapy Regenerative Medicine Revenue and Market Share by Application (2018-2023) 2.5.3 Global Cell Therapy Regenerative Medicine Sale Price by Application (2018-2023) 3 Global Cell Therapy Regenerative Medicine by Company 3.1 Global Cell Therapy Regenerative Medicine Breakdown Data by Company 3.1.1 Global Cell Therapy Regenerative Medicine Annual Sales by Company (2018-2023) 3.1.2 Global Cell Therapy Regenerative Medicine Sales Market Share by Company (2018-2023) 3.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Company (2018-2023) 3.2.1 Global Cell Therapy Regenerative Medicine Revenue by Company (2018-2023) 3.2.2 Global Cell Therapy Regenerative Medicine Revenue Market Share by Company (2018-2023) 3.3 Global Cell Therapy Regenerative Medicine Sale Price by Company 3.4 Key Manufacturers Cell Therapy Regenerative Medicine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Cell Therapy Regenerative Medicine Product Location Distribution 3.4.2 Players Cell Therapy Regenerative Medicine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Cell Therapy Regenerative Medicine by Geographic Region 4.1 World Historic Cell Therapy Regenerative Medicine Market Size by Geographic Region (2018-2023) 4.1.1 Global Cell Therapy Regenerative Medicine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Cell Therapy Regenerative Medicine Market Size by Country/Region (2018-2023) 4.2.1 Global Cell Therapy Regenerative Medicine Annual Sales by Country/Region (2018-2023) 4.2.2 Global Cell Therapy Regenerative Medicine Annual Revenue by Country/Region (2018-2023) 4.3 Americas Cell Therapy Regenerative Medicine Sales Growth 4.4 APAC Cell Therapy Regenerative Medicine Sales Growth 4.5 Europe Cell Therapy Regenerative Medicine Sales Growth 4.6 Middle East & Africa Cell Therapy Regenerative Medicine Sales Growth 5 Americas 5.1 Americas Cell Therapy Regenerative Medicine Sales by Country 5.1.1 Americas Cell Therapy Regenerative Medicine Sales by Country (2018-2023) 5.1.2 Americas Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) 5.2 Americas Cell Therapy Regenerative Medicine Sales by Type 5.3 Americas Cell Therapy Regenerative Medicine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Cell Therapy Regenerative Medicine Sales by Region 6.1.1 APAC Cell Therapy Regenerative Medicine Sales by Region (2018-2023) 6.1.2 APAC Cell Therapy Regenerative Medicine Revenue by Region (2018-2023) 6.2 APAC Cell Therapy Regenerative Medicine Sales by Type 6.3 APAC Cell Therapy Regenerative Medicine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Cell Therapy Regenerative Medicine by Country 7.1.1 Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2023) 7.1.2 Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) 7.2 Europe Cell Therapy Regenerative Medicine Sales by Type 7.3 Europe Cell Therapy Regenerative Medicine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Cell Therapy Regenerative Medicine by Country 8.1.1 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2023) 8.1.2 Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) 8.2 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Type 8.3 Middle East & Africa Cell Therapy Regenerative Medicine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine 10.3 Manufacturing Process Analysis of Cell Therapy Regenerative Medicine 10.4 Industry Chain Structure of Cell Therapy Regenerative Medicine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Cell Therapy Regenerative Medicine Distributors 11.3 Cell Therapy Regenerative Medicine Customer 12 World Forecast Review for Cell Therapy Regenerative Medicine by Geographic Region 12.1 Global Cell Therapy Regenerative Medicine Market Size Forecast by Region 12.1.1 Global Cell Therapy Regenerative Medicine Forecast by Region (2024-2029) 12.1.2 Global Cell Therapy Regenerative Medicine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Cell Therapy Regenerative Medicine Forecast by Type 12.7 Global Cell Therapy Regenerative Medicine Forecast by Application 13 Key Players Analysis 13.1 DePuy Synthes 13.1.1 DePuy Synthes Company Information 13.1.2 DePuy Synthes Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 DePuy Synthes Main Business Overview 13.1.5 DePuy Synthes Latest Developments 13.2 Medtronic 13.2.1 Medtronic Company Information 13.2.2 Medtronic Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.2.3 Medtronic Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Medtronic Main Business Overview 13.2.5 Medtronic Latest Developments 13.3 ZimmerBiomet 13.3.1 ZimmerBiomet Company Information 13.3.2 ZimmerBiomet Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 ZimmerBiomet Main Business Overview 13.3.5 ZimmerBiomet Latest Developments 13.4 Stryker 13.4.1 Stryker Company Information 13.4.2 Stryker Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.4.3 Stryker Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Stryker Main Business Overview 13.4.5 Stryker Latest Developments 13.5 Acelity 13.5.1 Acelity Company Information 13.5.2 Acelity Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.5.3 Acelity Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Acelity Main Business Overview 13.5.5 Acelity Latest Developments 13.6 MiMedx Group 13.6.1 MiMedx Group Company Information 13.6.2 MiMedx Group Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.6.3 MiMedx Group Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 MiMedx Group Main Business Overview 13.6.5 MiMedx Group Latest Developments 13.7 Organogenesis 13.7.1 Organogenesis Company Information 13.7.2 Organogenesis Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.7.3 Organogenesis Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Organogenesis Main Business Overview 13.7.5 Organogenesis Latest Developments 13.8 UniQure 13.8.1 UniQure Company Information 13.8.2 UniQure Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.8.3 UniQure Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 UniQure Main Business Overview 13.8.5 UniQure Latest Developments 13.9 Cellular Dynamics International 13.9.1 Cellular Dynamics International Company Information 13.9.2 Cellular Dynamics International Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Cellular Dynamics International Main Business Overview 13.9.5 Cellular Dynamics International Latest Developments 13.10 Osiris Therapeutics 13.10.1 Osiris Therapeutics Company Information 13.10.2 Osiris Therapeutics Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Osiris Therapeutics Main Business Overview 13.10.5 Osiris Therapeutics Latest Developments 13.11 Vcanbio 13.11.1 Vcanbio Company Information 13.11.2 Vcanbio Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.11.3 Vcanbio Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Vcanbio Main Business Overview 13.11.5 Vcanbio Latest Developments 13.12 Gamida Cell 13.12.1 Gamida Cell Company Information 13.12.2 Gamida Cell Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.12.3 Gamida Cell Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Gamida Cell Main Business Overview 13.12.5 Gamida Cell Latest Developments 13.13 Golden Meditech 13.13.1 Golden Meditech Company Information 13.13.2 Golden Meditech Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.13.3 Golden Meditech Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Golden Meditech Main Business Overview 13.13.5 Golden Meditech Latest Developments 13.14 Cytori 13.14.1 Cytori Company Information 13.14.2 Cytori Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.14.3 Cytori Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Cytori Main Business Overview 13.14.5 Cytori Latest Developments 13.15 Celgene 13.15.1 Celgene Company Information 13.15.2 Celgene Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.15.3 Celgene Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Celgene Main Business Overview 13.15.5 Celgene Latest Developments 13.16 Vericel Corporation 13.16.1 Vericel Corporation Company Information 13.16.2 Vericel Corporation Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 Vericel Corporation Main Business Overview 13.16.5 Vericel Corporation Latest Developments 13.17 Guanhao Biotech 13.17.1 Guanhao Biotech Company Information 13.17.2 Guanhao Biotech Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 Guanhao Biotech Main Business Overview 13.17.5 Guanhao Biotech Latest Developments 13.18 Mesoblast 13.18.1 Mesoblast Company Information 13.18.2 Mesoblast Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.18.3 Mesoblast Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 Mesoblast Main Business Overview 13.18.5 Mesoblast Latest Developments 13.19 Stemcell Technologies 13.19.1 Stemcell Technologies Company Information 13.19.2 Stemcell Technologies Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 Stemcell Technologies Main Business Overview 13.19.5 Stemcell Technologies Latest Developments 13.20 Bellicum Pharmaceuticals 13.20.1 Bellicum Pharmaceuticals Company Information 13.20.2 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product Portfolios and Specifications 13.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales, Revenue, Price and Gross Margin (2018-2023) 13.20.4 Bellicum Pharmaceuticals Main Business Overview 13.20.5 Bellicum Pharmaceuticals Latest Developments 14 Research Findings and Conclusion